Crossmark

Identifying core strategies and mechanisms for spreading a national medicines optimisation programme across England—a mixed-method study applying qualitative thematic analysis and Qualitative Comparative Analysis

Crossref DOI link: https://doi.org/10.1186/s43058-022-00364-5

Published Online: 2022-10-29

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ziemann, Alexandra https://orcid.org/0000-0002-5996-8484
Sibley, Andrew https://orcid.org/0000-0002-2503-5432
Tuvey, Sam

Robens, Sarah

Scarbrough, Harry
Funding

Funding for this research was provided by:

NHS England Innovation, Research and Life Sciences Team

AHSN Network
License Information

Text and Data Mining valid from 2022-10-29

Version of Record valid from 2022-10-29
More Information

Article History

Received: 1 April 2022

Accepted: 15 October 2022

First Online: 29 October 2022

Declarations

:

: Ethical approval for this study was obtained from City, University of London, The Business School Research Ethics Committee (ETH1920-1032). Participants provided their written consent by signing a consent form and their oral consent at the beginning of the interviews.

: Participants provided consent for publication by signing a consent form.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below